FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
ZURICH (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with him on the research after similar serious side effects emerged in recipients of its shot.
Andreas Greinacher, a transfusion medicine expert at Greifswald University, announced the collaboration after the European Medicines Agency said it would add a label to J&J's vaccine warning of unusual blood clots with low platelet counts. AstraZeneca's shot has a similar warning.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
